University of Leeds Featured PhD Programmes
Sheffield Hallam University Featured PhD Programmes
Imperial College London Featured PhD Programmes
The Francis Crick Institute Featured PhD Programmes
The Hong Kong Polytechnic University Featured PhD Programmes
"cancer"×
10 miles

The University of Manchester cancer PhD Projects, Programs & Scholarships

We have 55 The University of Manchester cancer PhD Projects, Programs & Scholarships

  • "cancer" ×
  • The University of Manchester×
  • clear all
Order by 
Showing 1 to 10 of 55
  (MRC DTP) Early detection of cancer using identification of volatile metabolites
  Dr J-M Schwartz, Prof P Townsend, Prof S Taylor
Application Deadline: 15 November 2019

Funding Type

PhD Type

Cancer is a disease which more than a third of the world population will get in their life. Different types of cancers have different prevalence and mortality rates, and it has been shown that advances in screening and diagnostic tools reduce mortality.
  (MRC DTP) The role of the lung microenvironment in regulating metastatic colonisation by breast cancer
  Dr R Clarke, Dr Ciara O'Brien, Dr R Eyre
Application Deadline: 15 November 2019

Funding Type

PhD Type

The metastatic spread of breast cancer cells and their colonisation of important organs such as the lungs is the cause of death in 95% of breast cancer.
  (MRC DTP) Development of a risk model towards personalised screening for radiation-induced breast cancer using the national Breast Screening After Radiotherapy Dataset (BARD)
  Dr M Aznar, Dr S Howell, Dr S Astley, Prof J Radford
Application Deadline: 15 November 2019

Funding Type

PhD Type

Radiotherapy uses radiation (x-rays, protons) to kill cancer cells, and is an important part of cancer treatment for many patients.
  The role of the microenvironment in regulating breast cancer metastatic colonisation
  Dr R Clarke, Dr Ciara O'Brien, Dr R Eyre
Applications accepted all year round

Funding Type

PhD Type

The metastatic spread of breast cancer cells and their colonisation of important organs is the cause of death in 95% of breast cancer.
  (MRC DTP) Understanding the role and regulation of a tumour suppressor’s oscillatory gene expression in cancer cell plasticity
  Prof N Papalopulu, Dr R Clarke, Dr T House
Application Deadline: 15 November 2019

Funding Type

PhD Type

Advances in breast cancer treatment mean that more patients survive cancer than ever before. However, in estrogen positive (ER+) breast cancer, the most common type of breast cancer, some patients either develop resistance to anti-estrogen therapies during the treatment itself or relapse after the end of treatment.
  Chemotherapy dose-capping due to obesity and its impact on survival
  Prof A Renehan, Dr Jorge Barriuso
Applications accepted all year round

Funding Type

PhD Type

Obesity is associated with risk for several cancer types, including colorectal and breast cancers (1). Obesity also predicts for a poor outcome after cancer treatment.
  (MRC DTP) Understanding how EDAR-signalling modulates susceptibility to skin and colorectal cancer
  Dr K Finegan, Prof K R Brennan
Application Deadline: 15 November 2019

Funding Type

PhD Type

This work will provide vital information to help stratify patients for EDAR-based therapy by determining the patient populations that are susceptible to oncogenic side-effects of these agents.
  What is the best way for healthcare professionals to communicate changes in estimated risk of breast cancer?
  Prof D French, Prof G Evans
Applications accepted all year round

Funding Type

PhD Type

Risk estimation models for common multifactorial diseases such as breast cancer are often used, e.g. in Family History Clinics to inform decisions about prevention options.
  (MRC DTP) Determining potential targets to enhance radiotherapy treatment of cancer by activating the immune system
  Dr M Travis, Prof K Williams, Prof T Illidge
Application Deadline: 15 November 2019

Funding Type

PhD Type

Cancer causes more than one in four of all deaths in the UK, and despite recent advances in therapy, much more still needs to be done to identify new treatments, and to make existing treatments more effective.
  (MRC DTP) What is the best way for healthcare professionals to communicate changes in estimated risk of breast cancer?
  Prof D French, Prof Anthony Howell, Dr L McWilliams, Prof G Evans
Application Deadline: 15 November 2019

Funding Type

PhD Type

Risk estimation models for common multifactorial diseases such as breast cancer are often used, e.g. in Family History Clinics to inform decisions about prevention options.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.